UM Develops Novel Oral Formulation for Ulcerative Colitis
July 06, 2024
July 06, 2024
MACAU, China, July 6 (TNSres) -- The University of Macau issued the following news release:
A research team led by Wang Ruibing, professor at the Institute of Chinese Medical Sciences (ICMS) at the University of Macau (UM), has developed a novel oral formulation for the targeted therapy of ulcerative colitis. The research results have been published in the prestigious international journal Science Advances.
Ulcerative colitis, a type of inflammatory bowel disease, is a . . .
A research team led by Wang Ruibing, professor at the Institute of Chinese Medical Sciences (ICMS) at the University of Macau (UM), has developed a novel oral formulation for the targeted therapy of ulcerative colitis. The research results have been published in the prestigious international journal Science Advances.
Ulcerative colitis, a type of inflammatory bowel disease, is a . . .